Clearmind Medicine receives approval to continue phase I trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. CRWV
10. NOW

Go back to Clearmind Medicine receives approval to continue phase I trial
(NASDAQ: CMND) Delayed: 3.43 +0.09 (2.69%)
Previous Close $3.34    52 Week High $ 
Open $3.28    52 Week Low $ 
Day High $3.55    P/E N/A 
Day Low $3.26    EPS $ 
Volume 95,283